Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.
Narducci MG, Tosi A, Frezzolini A, Scala E, Passarelli F, Bonmassar L, Monopoli A, Accetturi MP, Cantonetti M, Antonini Cappellini GC, De Galitiis F, Rosato A, Picozza M, Russo G, D'Atri S. Narducci MG, et al. Among authors: russo g. Front Immunol. 2020 Sep 25;11:579894. doi: 10.3389/fimmu.2020.579894. eCollection 2020. Front Immunol. 2020. PMID: 33072126 Free PMC article. Clinical Trial.
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.
Cristofoletti C, Bresin A, Picozza M, Picchio MC, Monzo F, Helmer Citterich M, Passarelli F, Frezzolini A, Scala E, Monopoli A, Cantonetti M, Benucci R, D'Atri S, Caprini E, Russo G, Narducci MG. Cristofoletti C, et al. Among authors: russo g. Leukemia. 2019 May;33(5):1231-1242. doi: 10.1038/s41375-018-0305-8. Epub 2018 Dec 5. Leukemia. 2019. PMID: 30518812 Free PMC article.
Sézary Syndrome, recent biomarkers and new drugs.
Cristofoletti C, Narducci MG, Russo G. Cristofoletti C, et al. Among authors: russo g. Chin Clin Oncol. 2019 Feb;8(1):2. doi: 10.21037/cco.2018.11.02. Epub 2018 Nov 28. Chin Clin Oncol. 2019. PMID: 30525758 Free article. Review.
Comprehensive analysis of PTEN status in Sezary syndrome.
Cristofoletti C, Picchio MC, Lazzeri C, Tocco V, Pagani E, Bresin A, Mancini B, Passarelli F, Facchiano A, Scala E, Lombardo GA, Cantonetti M, Caprini E, Russo G, Narducci MG. Cristofoletti C, et al. Among authors: russo g. Blood. 2013 Nov 14;122(20):3511-20. doi: 10.1182/blood-2013-06-510578. Epub 2013 Sep 23. Blood. 2013. PMID: 24062018 Free article.
IgE reactivity and survival probabilities in Sézary syndrome.
Scala E, Abeni D, Russo G, Narducci MG. Scala E, et al. Among authors: russo g. J Am Acad Dermatol. 2015 Jun;72(6):e177. doi: 10.1016/j.jaad.2015.02.1136. J Am Acad Dermatol. 2015. PMID: 25981030 No abstract available.
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E, Bresin A, Cristofoletti C, Helmer Citterich M, Tocco V, Scala E, Monopoli A, Benucci R, Narducci MG, Russo G. Caprini E, et al. Among authors: russo g. Cell Death Dis. 2018 Dec 5;9(12):1178. doi: 10.1038/s41419-018-1212-7. Cell Death Dis. 2018. PMID: 30518749 Free PMC article.
3,196 results